Literature DB >> 23959406

Cerebral arteriovenous malformation presenting with polycythemia vera: A case report and literature review.

Mairaj T Sami1, Bradley N Bohnstedt, Eyas M Hattab, Raymond Markham, Aaron A Cohen-Gadol.   

Abstract

INTRODUCTION: Cerebral arteriovenous malformations (AVM) usually present with headache, hemorrhage, or seizure. Erythropoietin (EPO) has demonstrated protective effects against ischemia within the CNS. PRESENTATION OF CASE: The authors report a patient with a cerebral AVM and concurrent polycythemia associated with elevated serum EPO. Systemic EPO levels declined acutely after resection of the patient's AVM, and the polycythemia resolved in the following months. DISCUSSION: Polycythemia secondary to a cerebral AVM, in the absence of extra-cerebral vascular lesions, has not been described in the literature.
CONCLUSION: The authors explore the mechanisms by which this patient's cerebral AVM could have induced EPO production within the brain, manifesting as polycythemia.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  AVM; Arteriovenous malformation; BBB; EPO; Erythropoietin; MRI; Microsurgical resection; Neurosurgical procedures; Polycythemia; TNFα; VEGF; arteriovenous malformations; blood–brain barrier; erythropoietin; magnetic resonance imaging; tumor necrosis factor-alpha; vascular endothelial growth factor

Year:  2013        PMID: 23959406      PMCID: PMC3785924          DOI: 10.1016/j.ijscr.2013.06.019

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  19 in total

1.  Erythropoietin: still on the neuroprotection road.

Authors:  Nelvys Subirós; Diana García Del Barco; Rosa M Coro-Antich
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

Review 2.  Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.

Authors:  A Tefferi; J W Vardiman
Journal:  Leukemia       Date:  2007-09-20       Impact factor: 11.528

3.  Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.

Authors:  Helen Kim; Hua Su; Shantel Weinsheimer; Ludmila Pawlikowska; William L Young
Journal:  Acta Neurochir Suppl       Date:  2011

4.  Erythropoietin gene expression in human, monkey and murine brain.

Authors:  H H Marti; R H Wenger; L A Rivas; U Straumann; M Digicaylioglu; V Henn; Y Yonekawa; C Bauer; M Gassmann
Journal:  Eur J Neurosci       Date:  1996-04       Impact factor: 3.386

Review 5.  Arteriovenous malformations.

Authors:  Ian G Fleetwood; Gary K Steinberg
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

Review 6.  Biology of vascular malformations of the brain.

Authors:  Gabrielle G Leblanc; Eugene Golanov; Issam A Awad; William L Young
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

Review 7.  Role of erythropoietin in the brain.

Authors:  Constance Tom Noguchi; Pundit Asavaritikrai; Ruifeng Teng; Yi Jia
Journal:  Crit Rev Oncol Hematol       Date:  2007-05-04       Impact factor: 6.312

8.  Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population.

Authors:  Rodney A Gabriel; Helen Kim; Stephen Sidney; Charles E McCulloch; Vineeta Singh; S Claiborne Johnston; Nerissa U Ko; Achal S Achrol; Jonathan G Zaroff; William L Young
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

Review 9.  Erythropoietin and the nervous system.

Authors:  Sermin Genc; Tolga F Koroglu; Kursad Genc
Journal:  Brain Res       Date:  2004-03-12       Impact factor: 3.252

Review 10.  Pleiotropic functions of erythropoietin.

Authors:  Ryuzo Sasaki
Journal:  Intern Med       Date:  2003-02       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.